SEEL: Seelos Therapeutics, Inc. Stock

by  •  • Comments Off on SEEL: Seelos Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3.82
Enterprise Value ($M) 15.03
Book Value ($M) -33.51
Book Value / Share -2.45
Price / Book -0.11
NCAV ($M) -33.52
NCAV / Share -2.45
Price / NCAV -0.11

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -1.60
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.14
Current Ratio 0.14

Balance Sheet (mrq) ($M)
Current Assets 5.40
Assets 5.42
Liabilities 38.93
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2.20
Operating Income -40.50
Net Income -37.88
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -23.91
Cash from Investing 0.00
Cash from Financing 11.38

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-06 13G Lind Global Fund II LP 9.90

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2024-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-01 50,523 309,026 16.35
2024-04-30 76,229 344,327 22.14
2024-04-29 134,766 462,436 29.14
2024-04-26 287,567 27,912 1,030.26

(click for more detail)

Similar Companies
SAVA – Cassava Sciences, Inc. SBFM – Sunshine Biopharma, Inc.
SCLX – Scilex Holding Company SHPH – Shuttle Pharmaceuticals Holdings, Inc.
SLRX – Salarius Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io